Sofregen Inc. Information

Sofregen is a manufacturer of a biomedical silk protein intended to facilitate soft-tissue bulking and regeneration for a range of procedures in medical aesthetics and other medical applications. Sofregen’s Silk Voice®, a silk protein injectable implant & catheter, was cleared by the U.S. FDA in 2019 for vocal fold medialization and vocal fold insufficiency.

Website	http://www.sofregen.com
Revenue	$6 million
Employees	8 (0 on RocketReach)
Founded	2014
Address	175 Crossing Boulevard Suite 510, Framingham, Massachusetts 01702, US
Phone	+1 617-651-8873
Technologies	JavaScript , HTML , Twitter +12 more (view full list)
Industry	Retail, Medical Equipment Manufacturing, Biotechnology
Keywords	Biomedical Materials, Soft Tissue Regeneration, Regenerative Medicine, Medical Aesthetics, Tissue Engineering, Medical Devices, Aesthetic Procedures, Protein Therapeutics, Wound Healing, Biomaterials, Surgical Materials, Biocompatible Materials, Dermal Fillers, Cosmetics, Pharmaceutical Products
Competitors	Baxter International Inc., STEMCELL Technologies, Organogenesis, Acelity, KCI USA, Sientra, Inc., Athersys, MediWound Ltd., Tissue Regenix Group, Edeniq, Inc. +46 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies